Cargando…
Recombinant Human Arresten and Canstatin Inhibit Angiogenic Behaviors of HUVECs via Inhibiting the PI3K/Akt Signaling Pathway
Angiogenetic inhibitors are crucial in tumor therapy, and endogenous angiogenesis inhibitors have attracted considerable attention due to their effectiveness, safety, and multi-targeting ability. Arresten and canstatin, which have anti-angiogenesis effects, are the c-terminal fragments of the α1 and...
Autores principales: | Zhu, Lingyu, Guo, Zitao, Zhang, Ji, Yang, Yuliang, Liu, Chunyu, Zhang, Liang, Gu, Zhenghua, Li, Youran, Ding, Zhongyang, Shi, Guiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409110/ https://www.ncbi.nlm.nih.gov/pubmed/36012259 http://dx.doi.org/10.3390/ijms23168995 |
Ejemplares similares
-
Cathepsin S degrades arresten and canstatin in infarcted area after
myocardial infarction in rats
por: SUGIYAMA, Akira, et al.
Publicado: (2019) -
Canstatin represses glioma growth by inhibiting formation of VM-like structures
por: Ma, Yuqiang, et al.
Publicado: (2021) -
Recombinant canstatin inhibits VEGF‐A‐induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC‐VII animal model
por: Hwang‐Bo, Jeon, et al.
Publicado: (2016) -
Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling
por: Sugiyama, Akira, et al.
Publicado: (2020) -
Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction
por: Sugiyama, Akira, et al.
Publicado: (2020)